The PI3K Inhibitor HCD Promotes Caspase Activation in Head and Neck Squamous Cells by Upregulating the Extrinsic and Intrinsic Apoptosis Pathways
Journal of Oral Pathology & Medicine · 2026-01 · 55 (1) · 61-72
DOI: 10.1111/jop.70060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, online erschienen am 15.09.2025. Verfasst von Leong-Perng Chan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Kaohsiung Medical University Hospital, Faculty of Medicine, College of Medicine, Kaohsiung M…. Hauptthemen laut MEDLINE: Apoptosis, Phosphoinositide-3 Kinase Inhibitors, Head and Neck Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science and Technology.
Abstract (Originalsprache)
Background
16‐hydroxycleroda‐3,13‐dien‐15,16‐olide (HCD), a compound isolated from Polyalthia longifolia var. pendula , has been identified as a PI3K inhibitor. P. longifolia var. pendula is recognized for its diverse pharmacological properties, including antimicrobial, hypotensive, anti‐inflammatory, and cytotoxic activities. Considering the pivotal role of PI3K in the regulation of apoptosis in cancer cells, this study aims to investigate the apoptotic effects induced by HCD in head and neck cancer cell models.
Methods
The study focused on investigating the mechanism through which HCD induces apoptosis in oral squamous cell carcinoma (OSCC) using SCC25 and SCC180 cells. These cells were treated with HCD at IC 20 , IC 50 , and IC 80 concentrations over periods of 24, 48, and 72 h. Assessments included cell viability, oxidative stress levels using MitoSOX and CellROX, and the analysis of gene and protein expressions related to apoptosis via immunofluorescence staining, flow cytometry, RT‐PCR, and western blotting.
Results
The results demonstrated that HCD significantly increased the sub‐G 1 phase cell population, suppressed clonogenic activity, and promoted mitochondrial ROS production, accompanied by a reduction in glutathione levels. HCD also activated cytochrome c (cyto. c ) release and Bax expression while downregulating Bcl‐2 expression. Notably, in SCC25 cells, HCD induced apoptosis through the TNF‐α/TNF‐R and FasL/Fas death domains, leading to caspase cascade activation. Moreover, HCD showed dose‐dependent growth inhibition of SCC25 cells, both alone and combined with cisplatin, by enhancing caspase‐3 expression.
Conclusion
This investigation into HCD's molecular mechanisms in OSCC cells offers insight into developing effective anticancer therapies, highlighting its role in apoptosis induction through oxidative stress, mitochondrial pathways, and death receptor signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, Kaohsiung Medical University Hospital, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Institute of Basic Medical Sciences, National Cheng Kung University, Tainan, Taiwan.
- Department of Internal Medicine, Division of Hematology and Oncology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Department of Otolaryngology-Head and Neck Surgery, Kaohsiung Municipal Siaogang Hospital, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Department of Cosmetic Science and Institute of Cosmetic Science, Chia nan University of Pharmacy and Science, Tainan, Taiwan.
- Department of Food and Drug Industry and Inspective Technology, Chia nan University of Pharmacy and Science, Tainan, Taiwan.
ORCID-Profile: Che-Wei Wu, Chih-Chuang Liaw, Chia-Hua Liang
Förderung
- Ministry of Science and Technology
Zitieren
APA
Chan, L. P., Tseng, Y. P., Wang, H. C., Chien, C. Y., Wu, C. W., Wang, L. F., Yen, T. W., Wang, P. C., Liaw, C. C., & Liang, C. H. (2026). The PI3K Inhibitor HCD Promotes Caspase Activation in Head and Neck Squamous Cells by Upregulating the Extrinsic and Intrinsic Apoptosis Pathways. Journal of Oral Pathology & Medicine, 55(1), 61-72. https://doi.org/10.1111/jop.70060
Vancouver
Chan LP, Tseng YP, Wang HC, Chien CY, Wu CW, Wang LF, et al. The PI3K Inhibitor HCD Promotes Caspase Activation in Head and Neck Squamous Cells by Upregulating the Extrinsic and Intrinsic Apoptosis Pathways. Journal of Oral Pathology & Medicine. 2026;55(1):61-72. doi:10.1111/jop.70060
BibTeX
@article{Chan2026,
author = {Chan, Leong-Perng and Tseng, Ya-Ping and Wang, Hui-Ching and Chien, Chen-Yu and Wu, Che-Wei and Wang, Ling-Feng and Yen, Tung-Wen and Wang, Po-Chun and Liaw, Chih-Chuang and Liang, Chia-Hua},
title = {The PI3K Inhibitor HCD Promotes Caspase Activation in Head and Neck Squamous Cells by Upregulating the Extrinsic and Intrinsic Apoptosis Pathways},
journal = {Journal of Oral Pathology & Medicine},
year = {2026},
volume = {55},
number = {1},
pages = {61--72},
doi = {10.1111/jop.70060}
}
EUVIMED